Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
Mohammed G MaslubMahasen A RadwanNur Aizati Athirah DaudAbubakar Sha'abanPublished in: European journal of medical research (2023)
More pharmacogenetic studies amongst diverse populations worldwide, like the Egyptian population, are necessary to detect further atorvastatin-gene interactions.